Nicholas Choo
Papers
1
Total Citations
67
H-Index
1
About
Nicholas Choo is a leading figure in preclinical oncology, specializing in the development of advanced 3D culture models for prostate cancer research. His work addresses a critical bottleneck in drug discovery: the scarcity of physiologically relevant preclinical models for this common but treatment-resistant malignancy. Choo’s major contribution, detailed in his highly cited 2021 study (67 citations), is a high-throughput imaging assay designed for drug screening using 3D prostate cancer organoids derived from patient-derived xenografts (PDXs). This innovative platform enables researchers to test candidate therapeutics on tumor tissue that closely mimics human disease, offering a more predictive alternative to traditional 2D cultures. By creating a scalable system for organoid-based screening, Choo has provided the field with a powerful tool to accelerate the identification of new treatments for advanced prostate cancer. His work bridges the gap between basic tumor biology and clinical application, making him a key contributor to the next generation of precision oncology tools.
Research Focus
Key Achievements
Top Papers
- 1